The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Olle T. H. Ringdén

Karolinska University Hospital

Centre for Allogeneic Stem Cell Transplantation

SE-141 86 Stockholm

Sweden

[email]@labmed.ki.se

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Karolinska University Hospital, Centre for Allogeneic Stem Cell Transplantation, SE-141 86 Stockholm, Sweden. 2009
  • Centre for Allogeneic Stem Cell Transplantation, Division of Clinical Immunology F79, Karolinska Institute, Huddinge University Hospital, Sweden. 2004 - 2006
  • Karolinska Institutet, Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Huddinge, Sweden. 2005

References

  1. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia. Ringdén, O., Labopin, M., Ehninger, G., Niederwieser, D., Olsson, R., Basara, N., Finke, J., Schwerdtfeger, R., Eder, M., Bunjes, D., Gorin, N.C., Mohty, M., Rocha, V. J. Clin. Oncol. (2009) [Pubmed]
  2. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center. Ringdén, O., Remberger, M., Svahn, B.M., Barkholt, L., Mattsson, J., Aschan, J., Le Blanc, K., Gustafsson, B., Hassan, Z., Omazic, B., Svenberg, P., Solders, G., von Döbeln, U., Winiarski, J., Ljungman, P., Malm, G. Transplantation (2006) [Pubmed]
  3. Introduction to graft-versus-host disease. Ringdén, O. Biol. Blood Marrow Transplant. (2005) [Pubmed]
  4. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications. Ringdén, O.T., Le Blanc, K., Remberger, M. Exp. Hematol. (2005) [Pubmed]
  5. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. Ringdén, O., Le Blanc, K. APMIS (2005) [Pubmed]
  6. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén, O., Labopin, M., Gorin, N.C., Le Blanc, K., Rocha, V., Gluckman, E., Reiffers, J., Arcese, W., Vossen, J.M., Jouet, J.P., Cordonnier, C., Frassoni, F. J. Clin. Oncol. (2004) [Pubmed]
  7. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?. Ringdén, O., Schaffer, M., Le Blanc, K., Persson, U., Hauzenberger, D., Abedi, M.R., Olerup, O., Ljungman, P., Remberger, M. Biol. Blood Marrow Transplant. (2004) [Pubmed]
 
WikiGenes - Universities